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LETTERS TO THE EDITOR

Physician Satisfaction Survey
on Continuing Medical
Education
Sir,
Continuing medical education (CME) is a platform for
keeping abreast with current knowledge and acquiring
new skills. Today, many countries are in various phases
of introducing and improving their academic activities for
physicians through different systems of evaluation.1,2
Among the available assessment tools to determine
effectiveness of CME, the four levels of Kirkpatrick's
evaluation model is usually preferred. Level-1 measures
participant satisfaction with the session; level-2
assesses changes in skills, attitude and knowledge;
level-3 ascertains the change in behaviour whereas
level-4 determines improved patient outcomes due to
change in behaviour. Quality and appropriateness of
CME events within the university setting were
determined through post-event (level-1) satisfaction
survey of the physicians, as evaluation of the
experienced physicians through other levels was quite
challenging and is influenced by a large number of
other factors.3 This is the first study of its kind in
Pakistan conducted at the Aga Khan University (AKU),
using a multi-item rating scale.
Nine hundred questionnaires were distributed to
determine physician satisfaction regarding the quality of
University CME activities offered over 3 months. Of
these, 800 were returned and 728 were completely
filled. These 81% forms were included in the study. The
participants were usually self-selected by the hosting
department and restricted to licensed physicians.
Informed consent was taken and strict confidentiality
was ensured.
The instrument used for the survey was developed on
ad hoc basis and consisting of 8 evaluative items rated
along a 5-point Likert scale (1 = poor to 5 = excellent).
The survey was designed to evaluate several areas of
CME activity, including appropriateness of the stated
objectives, content fitting the stated objectives,
presentation at the level of understanding, adequacy of
interaction, acquisition of new knowledge, time
management, queries responded, and administrative
support. The questionnaire was in English.
A rating of 3 or more points on the Likert scale were
defined as satisfactory; a rating of less than 3 was
defined as unsatisfactory. The data was entered in

Epidata version 3.1 and analyzed in Statistical Package
for Social Sciences 17.0 (SPSS, Inc., Chicago, IL,
USA). Descriptive statistics were performed on ratings
of each individual and results were recorded as
frequencies and percentages.
A total of 728 (81%) completely filled forms were
included in the study. Three or more points“satisfactory” ratings were given by 94% (682) of
participants for appropriateness of the stated objectives
of the session; 93% (679) for content fitting the stated
objectives; 91% (664) for presentation at the level of
understanding; 90% (654) for adequacy of interaction
between the facilitator and participants; 95% (692) for
acquisition of new knowledge; 94% (684) for time
management; 96% (699) and 93% (677) for satisfactory
responses to queries and administrative measures
respectively. However, fewer than three points“unsatisfactory” were given by 6% (46) of participants
for appropriateness of the stated objectives of the
session; 7% (49) for content according to the stated
objectives; 9% (64) for presentation at the level of
understanding; almost 10% (74) for facilitator-learner
interaction; 5% (36) for acquisition of new knowledge;
6% (44) for time management; 4% (29) and 7% (51) for
unsatisfactory responses to queries and administrative
measures respectively.
Medicine today encompasses not only patient
treatment, but also disease prevention, and the ability to
communicate and function within the social and cultural
milieu of the patient. Medical practitioners must have
ongoing means of accessing the knowledge and
attitudes needed to keep up with these ever-changing
requirements.4 The enhanced skills and knowledge of
physicians who attend CME activities lead to improved
patient care and disease outcomes.2,5
A primary limitation of this study is lack of generalization
being conducted in a single University. Another was that
the CME activities were hosted by different departments
within the University in which the participants were
usually self-selected which could have influenced the
results. The level of response was fairly high as the
participants were required to submit the post-event
feedback as a condition to get the course credit. The
study results might have projected differently if these
activities were opened to all within the University and it
is likely that the format of the survey instrument have
influenced the responses of the participants.
Nevertheless, this study has facilitated the department
of continuing professional education, AKU, to develop a
tool for measuring physicians' satisfaction with the CME
events and would also serve as a source of motivation
for other professional bodies within the region.
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Why is the Sustained Virological
Response Rate Among HCV
Genotype 3 Infected Patients
in Pakistan Low?

the effect of BMI that is a cause of insulin resistance as
a predictor of Sustained Virological Response (SVR).4 It
was better to check the Early Virological Response
(EVR: HCV-RNA negative after 3 months) for finding
non-responders to therapy. We would also like to
mention that the Rapid Virological Response (RVR:
HCV-RNA negative after 4 weeks of treatment) in the
selected group (patients with low HCV-RNA viral load)
can help in shortening the treatment period. It is an
important issue especially in context of the cost of the
treatment. However, the SVR in this article was 58% that
is much less than reported earlier by Aziz et al. and Munir
et al.5,6 Moreover, genetics is an important factor for ILB28 polymerase effect in high EVR and more relapse
between patients with genotype 3.7
5. We believe that quasi-experimental design was more
appropriate instead of cohort design for this study. At the
end, we would like to suggest checking of baseline viral
load quantitatively for determination of EVR, distinguishing between responders and non-responders and the
consequent side effects. Also, we would like to suggest
using baseline viral load as the main predictor for
response rate in developing countries.
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Sir,

We read with interest the article by Qureshi et al. in the
Journal.1 Treatment of hepatitis-C virus (HCV) infection
remains a global public health problem. Studies from
different countries are needed for determination of their
main risk factors and predictors and the best treatment
regimen. We would like to discuss more about reported
results in this article.
1. First of all, the authors have mentioned the dental
procedure history as a risk factor, while for confirmation
of this procedure as a risk factor, a case-control study is
required. The low prevalence of it (23%) is not enough
for this claim.
2. In addition, we would like to attract your attention to
more important risk factors like transfusion and unsafe
injection in Pakistan.2
3. Because of high prevalence of HBV infection in
Pakistan and in attention to 2-10% of anti-HCV positive
patient's seropositivity for HBV infection markers,3 it
seems that it was better to exclude patients who were
positive for HBsAg, but the authors did not consider the
HBsAg status in their patients.
4. We do not agree with consideration of weight as a
predictor factor; to our knowledge it was better to consider
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HCV continues to increase as a health problem both as
a result of a ever growing pool of non-responder and
relapsers and due to an increase of the disease burden
secondary to cirrhosis and hepatocellular carcinoma.
Studies from Western authors have evaluated pretreatment and on-treatment predictors of response in
attempts to optimize response rates. These have
invariably been conducted on genotypes 1, 2 and 3 and
have usually always reported the combined outcomes of
genotypes 2 and 3. The response rates of 80% for
genotype 3 appear to have been optimistic due to this
lumping of the two genotypes when quoting results, and
it seems that the response rate to genotype 3 alone is
lower, even with Pegylated interferon.1 Western studies
specially for the last 4 years have focused and
commented only on response rates with Pegylated
interferon and not with standard interferon. Our lower
response rates at the SVR stage must be seen in this
context and are consistent with recent Pakistani
studies.2 In addition, the lower response rates in our
study may not only be due to differences in the local viral
genotype 3 structure but may also be due to differences
in host immune responses due to HLA loci and IL28B
related differences in response to the virus.
Regarding dental procedure history, analysis of 8
published studies showed that histoy of dental treatment
was present in 10-60% of patients.3 Our study used a
validated questionnaire to determine the frequencies of
a history of dental procedures in this cohort. We are not
confirming or proving it as a risk factor. Obviously to
prove this association, a case control study would be
required.
All patients in this study were HBsAg negative as
mentioned in the methodology, all other causes of liver
disease were excluded.
We agree that BMI is a good marker for treatment
outcomes and is a marker for insulin resistance (IR) but
would like to stress that weight being the important
determinant of BMI remains globally a standard for
determining obesity and IR. Measurement of weight and
achieving weight loss early during HCV therapy may be
associated with improved treatment response.4
In our study, all patients were screened at one month for
rapid virological response (RVR) with a qualitative PCR.
RVR has a higher positive predictive value to identify
sustained responses. In those who do not achieve RVR,
an EVR is checked at 3 months. The negative predictive
value of an EVR is helpful in identifying the lack of
response and stopping treatment or extending it. Since
the positive predictive value of an EVR is lower than that
of RVR, RVR remains a better predictor for identifying a
better SVR.5
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Pyknodysostosis
Sir,

Pyknodysostosis is a rare condition characterised by
the presence of dense bones. It presents clinically as
dwarfism with fragile bones. We came across two siblings
with pyknodysostosis, parents of whom were first cousins.
Radiology plays an important role in its diagnosis.
These two siblings attended paediatric OPD with
complaints of short height and fractures on minor
trauma. No mental deficiency was noted. The parents
were first cousins, with average height. Their other 3
children were normal. On examination, children had
beaked noses and receding jaw line. The boy, aged 5
years was 95 cm in length (5th centile = 104.4 cm), and
the girl, aged 4 years, was 85 cm (5th centile = 97.2 cm).
Their skeletal survey revealed generalized dense bones.
Skull X-ray of both children showed wide fontanelle and
obtuse mandibles. Chest X-rays revealed dense ribs
and clavicles. Based on the history and radiological
features, a diagnosis of pyknodysostosis was made.
Pyknodysostosis is an autosomal recessive disorder.
The incidence of this disease is estimated at 1.7 per
million births.1 Radiologically, skull demonstrates
persistent fontanelle and dense bones (Figure 1),
particularly of orbital rims. This is known as the 'raccoon
mask' or Harlequin appearance sign.2 In addition, contradictory feature of premature closure of skull sutures has
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Figure 1: X-ray skull AP view: showing wide fontanelle which is abnormal for
age. Orbital rims are dense- 'Harlequin appearance'.

also been reported in literature.3 Mandible is hypoplastic
and obtuse. Lumbar vertebrae are spool shaped in
adults due to delayed fusion of neural arches.4
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The confirmatory laboratory test is Cathespin K gene
mutation analysis.5
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